References
- Soriano V, Barreiro P, Martin-Carbonero L, Castellares C, Ruiz-Sancho A, Labarga P, et al. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis. J Infect Dis 2007; 195: 1181–3
- Sulkowski MS. Treatment algorithm for the management of hepatitis C in HIV-coinfected persons. J Hepatol 2006; 44: S49–55
- Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palu G, et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005; 42: 615–24
- Salmon D, Robain M, Rockstroh JK, Benhamou Y. Therapeutic management of hepatitis and HIV infection in coinfected patients: results of a survey performed before the 2005 Consensus Conference. J Hepatol 2006; 44: S2–5
- Sulkowski M, Mehta S, Moore R, Montes de Oca R, Thomas D. Low rates of HCV therapy among treatment-eligible injection drug users with and without HIV coinfection. In: 14th CROI. Los Angeles, 2007.
- Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, et al. Pegylated interferon alpha-2b versus standard interferon alpha-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004; 292: 2839–48
- Chung R, Andersen J, Volberding P, Robbins G, Liu T, Sherman K, et al. Peginterferon alpha-2a plus ribavirin versus interferon alpha-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004; 351: 451–9
- Torriani F, Rodriguez-Torres M, Rockstroh J, Lissen E, Gonzalez-Garcia J, Lazzarin A, et al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004; 351: 438–50
- Pineda JA, Garcia-Garcia JA, Aguilar-Guisado M, Rios-Villegas MJ, Ruiz-Morales J, Rivero A, , et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 2007; 46:622–30.
- Uberti-Foppa C, De Bona A, Galli L, Sitia G, Gallotta G, Sagnelli C, et al. Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels. J Acquir Immune Defic Syndr 2006; 41: 63–7
- Sanchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis 2006; 43: 640–4
- Nunez M, Garcia-Samaniego J, Romero M, Portu J, Barreiro P, Bonet L, , et al The Presco trial: impact of higher ribavirin doses and longer duration of therapy with peginterferon alpha-2a plus ribavirin in HIV-infected patients with chronic hepatitis C. In: 57th AASLD. Boston, 2006.